Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Xu

P1.01-037 Circulating Tumor DNA Clearance During Treatment Associates With Improved Progression-Free Survival

Journal of Thoracic Oncology

English

P1.01-101 Survival Benefit of Sequential Therapy in ALK Positive Olioprogressive NSCLC Patients After Crizotinib Resistance

Journal of Thoracic Oncology

English

P1.01-57 the Role of EGFR Mutation as a Prognostic Factor in Survival After Diagnosis of Brain Metastasis in NSCLC: A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology

English

P1.04-33 Retrospective Descriptive Analysis of Metformin With Atezolizumab in Advanced Non-Small Cell Lung Cancer in the OAK Trial

Journal of Thoracic Oncology

English

P2.01-107 Analysis of Mutation Detection by ctDNA on the Basis of Metastatic Sites in Lung Adenocarcinoma Patients

Journal of Thoracic Oncology

English

P2.01-65 Assessment of Individual and Combined of Five Serum Tumor Markers for Lung Cancer

Journal of Thoracic Oncology

English

P2.01-109 Treatment Duration—A More Reasonable Definition to Evaluate the Efficacy of Crizotinib in ALK Positive Advanced NSCLC

Journal of Thoracic Oncology

English

P2.01-66 Comparison of EGFR Mutation Status in Tissue and Plasma Cell-Free DNA Detected by ARMS in Advanced Lung Adenocarcinoma Patients

Journal of Thoracic Oncology

English

Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors

American Journal of Transplantation

English

Sensitization to Minor Antigens Is a Significant Barrier in Bone Marrow Transplantation and Is Prevented by CD154:CD40 Blockade

American Journal of Transplantation

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Xu

P1.01-037 Circulating Tumor DNA Clearance During Treatment Associates With Improved Progression-Free Survival

P1.01-101 Survival Benefit of Sequential Therapy in ALK Positive Olioprogressive NSCLC Patients After Crizotinib Resistance

P1.01-57 the Role of EGFR Mutation as a Prognostic Factor in Survival After Diagnosis of Brain Metastasis in NSCLC: A Systematic Review and Meta-Analysis

P1.04-33 Retrospective Descriptive Analysis of Metformin With Atezolizumab in Advanced Non-Small Cell Lung Cancer in the OAK Trial

P2.01-107 Analysis of Mutation Detection by ctDNA on the Basis of Metastatic Sites in Lung Adenocarcinoma Patients

P2.01-65 Assessment of Individual and Combined of Five Serum Tumor Markers for Lung Cancer

P2.01-109 Treatment Duration—A More Reasonable Definition to Evaluate the Efficacy of Crizotinib in ALK Positive Advanced NSCLC

P2.01-66 Comparison of EGFR Mutation Status in Tissue and Plasma Cell-Free DNA Detected by ARMS in Advanced Lung Adenocarcinoma Patients

Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors

Sensitization to Minor Antigens Is a Significant Barrier in Bone Marrow Transplantation and Is Prevented by CD154:CD40 Blockade